Investlytic Investlytic
Log in Free Account
English
🕒 Last update: loading…17/09/2026

Stock Pfizer Inc. PFE

Pfizer Inc. — Investlytic score 2/5 on the five criteria.

-
-
40/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 2/5 criteria met. Data as of 17/09/2026.

  • ❌ Price trend failed
  • ⚠️ Mixed growth
  • ❌ Debt failed
  • ✅ P/E passed
  • ✅ Correction passed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2018 → 2019: -10.25%

Price change 2019 → 2020: -0.89%

Price change 2020 → 2021: 60.42%

Price change 2021 → 2022: -13.23%

Price change 2022 → 2023: -43.81%

Price change 2023 → 2024: -7.85%

Price change 2024 → 2025: -6.14%

Price change 2025 → 2026: 0.44%

Price change 2026 (year to date): -0.68%

Financial growth

Revenue CAGR (8 years): 2.22%

Earnings CAGR (8 years): -5.03%

Growth status: positive trend (>1%/yr) in revenue OR earnings, but not both.

Debt

Debt-to-equity ratio: 0.78

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 9.11

P/E < 25.0 (maximum threshold).

Correction (6 months)

Current correction: 12.40% from the high over 6 months.

Correction between 10.0% and 20.0% (target range).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

Create a free account Log in
02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Pfizer Inc.9.80.78−0.5 %🔒
AstraZeneca PLC18.50.61+3.9 %–
Sanofi8.80.28+2.5 %–
EssilorLuxottica S.A.33.60.37+14.2 %–
Moderna, Inc.–0.22+37.8 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

Create a free account Log in
04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

Create a free account Log in
05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

Create a free account Log in
06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

Create a free account Log in
07

Similar stocks